Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Brickell Biotech Inc (BBI)

Brickell Biotech Inc (BBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,754
  • Shares Outstanding, K 2,874
  • Annual Sales, $ 400 K
  • Annual Income, $ -39,470 K
  • 60-Month Beta 0.02
  • Price/Sales 16.36
  • Price/Cash Flow N/A
  • Price/Book 0.40
Trade BBI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -13.52
  • Most Recent Earnings $-0.01 on 08/11/22
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -1.59
  • Number of Estimates 2
  • High Estimate -1.35
  • Low Estimate -1.82
  • Prior Year -7.21
  • Growth Rate Est. (year over year) +77.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.21 +6.33%
on 09/07/22
4.10 -42.68%
on 08/08/22
-1.42 (-37.67%)
since 08/05/22
3-Month
2.21 +6.33%
on 09/07/22
12.60 -81.35%
on 06/29/22
-3.95 (-62.70%)
since 06/07/22
52-Week
2.21 +6.33%
on 09/07/22
37.35 -93.71%
on 09/08/21
-34.55 (-93.63%)
since 09/07/21

Most Recent Stories

More News
Brickell Biotech to Participate at William Blair Biotech Focus Conference 2022

BOULDER, Colo., July 06, 2022 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical...

BBI : 2.35 (+2.17%)
Brickell Biotech Announces 1-For-45 Reverse Stock Split

Common stock will begin trading on a split-adjusted basis on July 5, 2022...

BBI : 2.35 (+2.17%)
Brickell Biotech Reports First Quarter 2022 Financial Results and Provides Corporate Update

Completed sale of sofpironium bromide to Botanix Pharmaceuticals for up to $9 million in upfront and potential near-term regulatory milestone payments,...

BBI : 2.35 (+2.17%)
Brickell Biotech to Report First Quarter 2022 Financial Results and Provide a Corporate Update on May 12, 2022

BOULDER, Colo., May 05, 2022 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical...

BBI : 2.35 (+2.17%)
Brickell Biotech Announces Adjournment of Annual Meeting of Stockholders

Meeting adjourned to May 17, 2022 at 10 a.m. MT Brickell encourages all stockholders of record on March 7, 2022 who have not yet voted to do so by 11:59...

BBI : 2.35 (+2.17%)
Brickell Biotech Announces Sale of Sofpironium Bromide to Botanix Pharmaceuticals

Deal includes up to $9 million in upfront and potential near-term regulatory milestone payments, $168 million in potential future regulatory and sales...

BBI : 2.35 (+2.17%)
Brickell Biotech Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Broadened strategic focus and expanded pipeline in immunology and inflammation following acquisition of rights to BBI-02, a potential first-in-class oral...

BBI : 2.35 (+2.17%)
Brickell Biotech to Report Fourth Quarter and Full Year 2021 Financial Results and Provide a Corporate Update on March 15, 2022

BOULDER, Colo., March 08, 2022 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical...

BBI : 2.35 (+2.17%)
Brickell Biotech Acquires Exclusive Global Rights to Portfolio of Novel STING Inhibitors Targeting Autoimmune and Inflammatory Diseases from Carna Biosciences

Lead STING inhibitor candidate, BBI-10, demonstrated dose-dependent cytokine reduction in nonclinical in vitro and in vivo studies providing strong...

BBI : 2.35 (+2.17%)
Brickell Biotech Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Announced positive topline results from the Phase 3 pivotal clinical studies of sofpironium bromide gel, 15% in primary axillary hyperhidrosis patients;...

BBI : 2.35 (+2.17%)

Business Summary

Brickell Biotech, Inc. is a clinical-stage pharmaceutical company. It is focused on developing prescription therapeutics for treatment of skin diseases. The company's pipeline consists of therapeutics for hyperhidrosis, cutaneous T-cell lymphoma, psoriasis, and other prevalent severe skin diseases. ...

See More

Key Turning Points

3rd Resistance Point 2.57
2nd Resistance Point 2.47
1st Resistance Point 2.41
Last Price 2.35
1st Support Level 2.25
2nd Support Level 2.15
3rd Support Level 2.09

See More

52-Week High 37.35
Fibonacci 61.8% 23.93
Fibonacci 50% 19.78
Fibonacci 38.2% 15.63
Last Price 2.35
52-Week Low 2.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar